Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...

Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic's LINQ II cardiac monitor. The ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can be used by the NHS to monitor heart failure patients with implantable devices, but two others from Biotronik ...

HxM™ BT Solution Advantage The HxM™ BT Solution takes personal fitness monitoring to a new level. Real-time feedback including heart rate, speed and distance measures, combined with a focus on ...

Medtronic plc (NYSE:MDT – Get Free Report) has received a consensus rating of “Hold” from the sixteen ratings firms that are ...

Shares of Medtronic plc (NYSE:MDT – Get Free Report) shot up 0.1% during mid-day trading on Friday following a dividend announcement from the company. The company traded as high as $93.27 and last ...

Revenue for Medtronic’s Cardiac Ablation Solutions business increased ... its customer base and strengthened its continuous glucose monitor (CGM) attachment rates, as per the earnings release.